Recently, anti-ganglioside complex (GSC) antibodies were discovered among the various subtypes of Guillain-Barré syndrome. GSC is the novel glycoepitopes formed by two individual ganglioside molecules.
INTRODUCTION

CASE REPORT
A 36-year-old man was admitted with diplopia, oral paresthesia, dysarthria and gait disturbance 7 days after suffering from a common cold. On admission, the patient anti-GT1a antibody without GQ1b reactivity is essential for the occurrence of bulbar palsy in patients with GBS. However, the patient's serum IgG binds strongly to GSCs such as GM1/GT1a, GM1/GQ1b, GD1b/GQ1b and GD1a/GT1a, but only equivocally to GQ1b. Previous studies reported that
IgG antibodies to at least one GSC including anti-GM1/ GQ1b, GM1/GT1a, GD1b/GQ1b, GD1b/GT1a are present in 41% of MFS and 28% of GBS with ophthalmoplegia accompanying sensory dysfunction. 6 Additionally, antibodies to GD1a/GQ1b, GD1a/GT1a, GT1b/GQ1b, GT1b/GT1a are present in 6% of MFS and 19% of GBS with ophthalmoplegia. 6 Therefore, anti-GSC antibodies in present study seem to be associated with clinical symptoms overlapping MFS and ABP.
Since the patients showed fever and CSF pleocytosis, 
